Americans are increasingly utilizing GLP-1 agonists—a class of medications that help manage blood sugar, or glucose, levels in people with type 2 diabetes—to lose weight quickly. With all the buzz and popularity surrounding these drugs, legal challenges have ensued. This article highlights a few of those challenges.
